export const ABBVIE_CONVERSATION = [
    {
        id: 1,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "Good afternoon, Dr. Lee. I’m Emily from AbbVie. Thanks for meeting with me today.",
    },
    {
        id: 2,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'Good afternoon, Emily. I’ve heard about Humira, but I’d like to know more about its recent developments.',
    },
    {
        id: 3,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "Absolutely. Humira is one of our leading treatments for a wide range of conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis, among others. It’s a TNF inhibitor, working by targeting the tumor necrosis factor to help reduce inflammation.",
    },
    {
        id: 4,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'What are some of the latest indications for Humira?',
    },
    {
        id: 5,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "One of the recent indications is for non-infectious uveitis, which is a condition that can lead to blindness if untreated. Humira has also been approved for use in pediatric patients with moderate to severe Crohn's disease. We’ve been seeing significant benefits in terms of reducing symptoms and helping patients achieve remission.",
    },
    {
        id: 6,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'How does Humira compare to other biologics on the market for inflammatory diseases?',
    },
    {
        id: 7,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "Humira has been one of the most widely used biologics, with over 20 years of clinical experience. It’s known for its safety and efficacy profile across multiple indications. The subcutaneous administration is convenient for patients, and we have strong long-term data supporting its use in maintaining remission and controlling inflammation.",
    },
    {
        id: 8,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'What about safety? Are there any specific side effects or monitoring requirements?',
    },
    {
        id: 9,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "The most common side effects are infections, since TNF inhibitors can suppress the immune system. Patients should be monitored for signs of infection, tuberculosis, and malignancies. We recommend regular testing before and during treatment, such as TB screening and liver function tests.",
    },
    {
        id: 10,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'And how does Humira perform in terms of long-term use? Do patients tend to build up resistance?',
    },
    {
        id: 11,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "Humira has been shown to maintain efficacy over the long term, but, as with any biologic, some patients may develop antibodies over time that could reduce the drug’s effectiveness. In those cases, a switch to another TNF inhibitor or treatment class might be necessary. That being said, many patients have been on Humira for years and continue to do well.",
    },
    {
        id: 12,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: "That’s good to hear. What sort of patient support programs does AbbVie offer for Humira?",
    },
    {
        id: 13,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "We have an extensive patient support program called **Humira Complete**. It includes financial assistance options, home delivery services, and nurse ambassadors who can help patients manage their condition and understand how to self-administer the medication. The goal is to provide comprehensive support to ensure adherence and optimize outcomes.",
    },
    {
        id: 14,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'That sounds like a valuable resource. Can you tell me more about the administration? Is it difficult for patients to self-inject?',
    },
    {
        id: 15,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "Humira is available as a pre-filled syringe or a pen, both designed for subcutaneous injection. Most patients find the pen device easy to use, and the self-administration process is straightforward with proper training. Our nurse ambassadors provide injection training, either in person or via telehealth, to ensure patients are comfortable with the process.",
    },
    {
        id: 16,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'Great. Are there any data on the real-world effectiveness of Humira?',
    },
    {
        id: 17,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "Yes, we have a lot of real-world data supporting Humira’s effectiveness, especially in maintaining remission in conditions like Crohn’s disease and rheumatoid arthritis. In long-term follow-ups, many patients continue to show stable disease control with a well-tolerated safety profile.",
    },
    {
        id: 18,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'That’s very reassuring. Thanks for the comprehensive overview, Emily. I’ll certainly consider Humira for my patients.',
    },
    {
        id: 19,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: "Thank you, Dr. Lee. I'll send over some additional materials, including information on our support programs. Feel free to reach out if you need anything further.",
    },
    {
        id: 20,
        speaker: {
            value: 'DrLee',
            label: 'Dr. Lee (Male)',
        },
        text: 'Will do. Thanks again, Emily.',
    },
    {
        id: 21,
        speaker: {
            value: 'Emily',
            label: 'Emily (Female)',
        },
        text: 'You’re welcome. Have a great day, Dr. Lee!',
    },
];
